Developmental haemostasis - Impact for clinical haemostasis laboratories

被引:391
作者
Monagle, P
Barnes, C
Ignjatovic, V
Furmedge, J
Newall, F
Chan, A
De Rosa, L
Hamilton, S
Ragg, P
Robinson, S
Auldist, A
Crock, C
Roy, N
Rowlands, S
机构
[1] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Dept Anaesthesiol, Melbourne, Vic, Australia
[3] Royal Childrens Hosp, Dept Surg, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[5] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[6] McMaster Univ, Dept Paediat, Hamilton, ON L8S 4L8, Canada
[7] Royal Hosp Women, Dept Neonatol, Melbourne, Vic, Australia
[8] Royal Hosp Women, Dept Obstet, Melbourne, Vic, Australia
关键词
reference ranges; developmental haemostasis; paediatric;
D O I
10.1160/TH05-01-0047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Developmental haemostasis is a concept, now universally accepted, introduced by Andrew et al. in the late 1980's. However, coagulation analysers and reagents have changed significantly over the past 15 years. Coagulation testing is known to be sensitive to changes in individual reagents and analysers. We hypothesised that the reference ranges developed by Andrew et al. may not be appropriate for use in a modern coagulation laboratory. Our study was designed to determine whether a current day coagulation testing system (STA Compact analyser and Diagnostica Stago reagent system) was sensitive to age-related changes in coagulation assays. This is the first large scale study since Andrew et al. to determine the age associated numerical changes in coagulation proteins. Our results confirm the concepts of developmental haemostasis elucidated by Andrew et al. However, our results clearly demonstrate that the absolute values of reference ranges for coagulation assays in neonates and children vary with analyser and reagent systems. The results confirm the need for coagulation laboratories to develop age-related reference ranges specific to their own testing systems. Without this, accurate diagnosis and management of neonates and children with suspected bleeding or clotting disorders is not possible. Finally we present age related reference ranges for D-dimers,TFPI, and endogenous thrombin potential, previously not described.
引用
收藏
页码:362 / 372
页数:11
相关论文
共 33 条
[1]  
ANDREW M, 1988, BLOOD, V72, P1651
[2]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[3]  
ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
[4]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[5]  
ANDREW M, 1995, THROMB HAEMOSTASIS, V74, P415
[6]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[7]  
Barnes C, 2004, J CHILD NEUROL, V19, P218
[8]  
Barnes C, 2001, THROMB HAEMOSTASIS, V86, P1341
[9]   A549 LUNG EPITHELIAL-CELLS SYNTHESIZE ANTICOAGULANT MOLECULES ON THE CELL-SURFACE AND MATRIX AND IN CONDITIONED MEDIA [J].
BERRY, L ;
ANDREW, M ;
POST, M ;
OFOSU, F ;
OBRODOVICH, H .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1991, 4 (04) :338-346
[10]   ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY [J].
BRILLEDWARDS, P ;
GINSBERG, JS ;
JOHNSTON, M ;
HIRSH, J .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :104-109